INCREASES in urinary aestradiol values amounting to 10 ,ug/day, without corresponding increases in cestrone and cestriol, when measured by the method of Brown (1955) , were observed in a subject given norethisterone acetate (12 mg/day orally). When a saponification step was incorporated in the method (Brown et al., 1957), increases in both cestradiol and cestrone values of 8 and 13 pig/day respectively were observed without any change in the cestriol. Quantitatively similar results were obtained in all of 6 women given norethisterone or its acetate orally, or its oenanthate intramuscularly. Similar observations have been made by Parada et al. (1959) and by Breuer et al. (1960) who isolated and identified the cestrone following saponification. The failure of the cestriol to increase under these conditions shows that the increases in cestrone and cestradiol are due to an artifact derived from the norethisterone. Experiments showed that this was a metabolite of norethisterone and that it was not a ketone but was converted to cestrone on saponification. Engel et al. (1958) showed that 19-nortestosterone is converted in vivo to cestradiol and 0 03% of the dose is excreted in the urine as cestrone. The possibility was considered that norethisterone is similarly metabolized to ethynyleestradiol. Ethynyleestradiol gives onetenththeintensityofcolourgivenbycestradiolin the Kober reaction; when ethynylcestradiol was added directly to urine and measured by the method of Brown, 50% was destroyed during acid hydrolysis -and 30% was recovered in the cestradiol fraction without any appearing in the cestrone or cestriol fractions; when saponification was included, 22 % was recovered in the cestradiol fraction and 8 % was recovered as cestrone. These figures fit exactly those found following the administration of norethisterone and its esters. They also agree with those of Langecker (1959) who showed that ethynylcestradiol, on boiling with alkali, is converted in 20 % yield to cestrone with the liberation of acetylene. Therefore all the evidence indicates that ethynyloestradiol is a metabolite of norethisterone. Further experiments showed that ethynyloestradiol is not liberated by incubation with P-glucuronidase and phenolsulphatase (Patella vulgata) from the urine of individuals receiving norethisterone although it is liberated in increased yields (150% of acid hydrolysis) when ethynylcestradiol itself is administered.
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The amounts of ethynyleestradiol excreted per day during the administration of ethynyleestradiol and of norethisterone and its esters were calculated from the urinary cestradiol and cestrone values obtained following acid hydrolysis (Table  I ). The results indicated that a dose of 12-30 mg norethisterone is converted in the body to approximately 1 mg ethynyloestradiol, 12-5 % of which is recovered in the urine as ethynyloestradiol. While norethisterone has cestrogenic properties, it does not appear to be as active in this respect as these doses of ethynylcestradiol would indicate. Possible explanations for this might be that the conversion occurs in the liver and little of the ethynylcestradiol reaches the general circulation before it is excreted; or the substance excreted in the urine is not ethynylcestradiol but is converted to it during acid hydrolysis. However, the possibility that some of the biological properties of norethisterone and its esters, such as pituitary inhibition, might be due to conversion in vivo to relatively large amounts of a potent cestrogen should not be overlooked.
